Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of Biomolecular Screening
|
April 9, 2013
A phenotypic screening assay for modulators of huntingtin-induced transcriptional dysregulation
Giulia Lazzeroni, Tiziana Benicchi, Freddy Heitz, et al.
Journal of Huntington'S Disease
|
July 27, 2014
Reference genes selection for transcriptional profiling in blood of HD patients and R6/2 mice
Daniela Diamanti, Nayana Lahiri, Alessia Tarditi, et al.
BMC Biochemistry
|
November 27, 2013
Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells
Luisa Massai, Lara Petricca, Letizia Magnoni, et al.
International Journal of Cancer
|
November 11, 2011
In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines
Pietro Ferruzzi, Federica Mennillo, Antonella De Rosa, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin Toxicity
Salvatore La Rosa, Tiziana Benicchi, Laura Bettinetti, et al.
The Pharmacogenomics Journal
|
January 29, 2019
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib
Marta Schirripa, Beatrice Borelli, Romina D'Aurizio, et al.
Neurobiology of Disease
|
June 24, 2008
Increased expression of the oligopeptidase THOP1 is a neuroprotective response to Abeta toxicity
Giuseppe Pollio, Jeroen J M Hoozemans, Claus A Andersen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 19, 2016
Multimodal molecular imaging system for pathway-specific reporter gene expression
Marco Rossi, Luisa Massai, Daniela Diamanti, et al.
Human Molecular Genetics
|
January 18, 2014
A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease
Marianne R Smith, Adeela Syed, Tamas Lukacsovich, et al.
Nature Communications
|
June 19, 2015
A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours
Madhuri Kalathur, Alberto Toso, Jingjing Chen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of Biomolecular Screening
|
April 9, 2013
A phenotypic screening assay for modulators of huntingtin-induced transcriptional dysregulation
Giulia Lazzeroni, Tiziana Benicchi, Freddy Heitz, et al.
Journal of Huntington'S Disease
|
July 27, 2014
Reference genes selection for transcriptional profiling in blood of HD patients and R6/2 mice
Daniela Diamanti, Nayana Lahiri, Alessia Tarditi, et al.
BMC Biochemistry
|
November 27, 2013
Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells
Luisa Massai, Lara Petricca, Letizia Magnoni, et al.
International Journal of Cancer
|
November 11, 2011
In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines
Pietro Ferruzzi, Federica Mennillo, Antonella De Rosa, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin Toxicity
Salvatore La Rosa, Tiziana Benicchi, Laura Bettinetti, et al.
The Pharmacogenomics Journal
|
January 29, 2019
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib
Marta Schirripa, Beatrice Borelli, Romina D'Aurizio, et al.
Neurobiology of Disease
|
June 24, 2008
Increased expression of the oligopeptidase THOP1 is a neuroprotective response to Abeta toxicity
Giuseppe Pollio, Jeroen J M Hoozemans, Claus A Andersen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 19, 2016
Multimodal molecular imaging system for pathway-specific reporter gene expression
Marco Rossi, Luisa Massai, Daniela Diamanti, et al.
Human Molecular Genetics
|
January 18, 2014
A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease
Marianne R Smith, Adeela Syed, Tamas Lukacsovich, et al.
Nature Communications
|
June 19, 2015
A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours
Madhuri Kalathur, Alberto Toso, Jingjing Chen, et al.
Page
of 3